Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04399655
Other study ID # 01/2020
Secondary ID 2020-A00209-30
Status Completed
Phase
First received
Last updated
Start date November 12, 2020
Est. completion date June 4, 2022

Study information

Verified date June 2022
Source Clinique Néphrologique Saint-Exupéry
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Chronic hemodialysis is often associated with a reduction in the quality of life of patients and a reduction in physical activity, due to the repeated frequency of sessions. Various studies conducted in hemodialysis patients have shown the beneficial effects of physical exercise during hemodialysis sessions on reducing cardiovascular risk, the number of hospitalizations and improving quality of life. It also contributes to improved patient adherence to care. Finally, it has been shown that exercise during the hemodialysis session is safe for the patient and does not disrupt dialysis parameters. Nevertheless, there are no data on the medico-economic impact of such a program. Based on the investigators' experience, the investigators have developed a specific protocol linking the different types of physical activity that have provided evidence of their efficiency and used in standard practice in the investigators' institutions. From tests and questionnaires assessing the physical abilities of patients have already validated for this population in this pathology. The objective of this project is to show the medico-economic interest of an adapted physical activity program for hemodialysis patients.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date June 4, 2022
Est. primary completion date June 4, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient dependent on the CPAM Haute Garonne, - Patient affiliated to or beneficiary of a French social security scheme, - Haemodialysis patient for more than 12 months and in front of benefiting/benefiting from a physical activity program, - Patient age = at 18 years old, - French speaking patient. Exclusion Criteria: - Patient with cancer, hepatitis, stage 4 arterial disease, arteritis or amputation of a limb - Pregnant or breastfeeding women according to article L.1121-5 of the CSP, - Vulnerable persons according to article L.1121-6 of the CSP, - Persons of full age under guardianship or curatorship or under safeguard of justice, - Patient unable to personally give his or her consent, or age of majority protected by law, - Opposition expressed to inclusion in the study.

Study Design


Locations

Country Name City State
France Clinique Néphrologique Saint Saint-Exupéry Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Clinique Néphrologique Saint-Exupéry

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Variation in direct and indirect medical costs Evaluation of medical costs between the 12 months prior to the start of the adapted physical activity program and the 12 months following the start of the adapted physical activity program. through study completion, an average of 1 year
Secondary change in the quality of life score Assessed by a The Short Form (36) (SF-36 scale) interpreted by an algorythm baseline, at 6 months and at one year
Secondary change in body mass index, weight and height will be combined to report BMI in kg/m^2 obtained in start of hemodialysis session every month, up to 12 months
Secondary change in blood presure in mmHg obtained in start of hemodialysis session every month, up to 12 months
Secondary change in rate of haemoglobin in g/dL obtained in start of hemodialysis session every month, up to 12 months
Secondary change in percentage of hematocrit and saturation coefficient in % obtained in start of hemodialysis session every month, up to 12 months
Secondary change in rate of ferritin in ug/L obtained in start of hemodialysis session every month, up to 12 months
Secondary change in rate of urea, transferrin and blood sugar in g/L obtained in start of hemodialysis session every month, up to 12 months
Secondary change in rate of potassium in mEq/L obtained in start of hemodialysis session every month, up to 12 months
Secondary change in rate of bicarbonate in mmol/L obtained in start of hemodialysis session every month, up to 12 months
Secondary change in rate of calcium, phosphore and C-reactiv protein in mg/L obtained in start of hemodialysis session every month, up to 12 months
Secondary change in physical activity evaluation score, from 0 (better) to 20 (worse) obtained thanks to Borg scale baseline, at 6 months and at one year
See also
  Status Clinical Trial Phase
Terminated NCT05056727 - A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia Phase 3
Withdrawn NCT01655186 - A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus Phase 2
Completed NCT03481686 - Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections N/A
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Enrolling by invitation NCT02237534 - Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia Phase 4
Completed NCT02126293 - Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant Phase 3
Terminated NCT01533545 - Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients N/A
Completed NCT03280615 - Omega 3 Fatty Acids in Patients With Chronic Renal Disease Phase 3
Completed NCT04498156 - Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
Recruiting NCT04020328 - Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency Phase 4
Recruiting NCT06366529 - Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
Active, not recruiting NCT04876963 - HOLT-ED: Holter-monitoring in End-stage Renal Disease
Completed NCT03836508 - Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis N/A
Completed NCT03250715 - Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure N/A
Completed NCT03577249 - Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation Phase 2/Phase 3
Completed NCT01975818 - Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 Phase 2
Active, not recruiting NCT05766644 - App-based Education Program for CKD N/A
Active, not recruiting NCT02791880 - Acute Kidney Injury Genomics and Biomarkers in TAVR Study
Recruiting NCT02947750 - Neurovascular Transduction During Exercise in Chronic Kidney Disease Phase 2
Terminated NCT02286258 - Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) Phase 1/Phase 2